Form 4: UnitedHealth Group Director Receives Deferred Stock Units

Sentiment:

Statement of Changes in Beneficial Ownership


A director at UnitedHealth Group has been granted deferred stock units as part of their regular quarterly compensation.

Summary

  • Michele J. Hooper, a director at UnitedHealth Group Inc., received 112 deferred stock units on January 2, 2025.
  • These units were granted as part of her regular quarterly compensation for serving on the board.
  • The units are immediately vested but cannot be accessed until Hooper's service on the board concludes.
  • Following this transaction, Hooper owns a total of 39,780 shares of UnitedHealth Group common stock.

Sentiment

Score: 7

Explanation: The document reflects a routine and positive event (granting of deferred stock units to a director) with no negative implications, hence a moderately positive sentiment.

Positives

  • The grant of deferred stock units aligns the director's interests with those of shareholders.
  • Immediate vesting of the units demonstrates the company's commitment to its directors.
  • The transaction is part of regular compensation, indicating a stable and predictable remuneration structure.

Negatives

  • The document does not disclose any negative aspects of the transaction.

Risks

  • There are no specific risks detailed in the document.

Future Outlook

The document does not provide any explicit forward-looking statements.

Management Comments

  • The document does not contain any direct quotes from management.

Industry Context

This announcement is typical for director compensation within large publicly traded companies in the healthcare sector. Deferred stock units are a common method for aligning director interests with shareholder value.

Comparison to Industry Standards

  • UnitedHealth Group's practice of granting deferred stock units to directors is consistent with industry standards.
  • For example, other major healthcare companies like Anthem and CVS Health also utilize similar compensation structures for their board members.
  • This approach is generally viewed favorably as it promotes long-term value creation and aligns the interests of directors with those of shareholders.

Stakeholder Impact

  • Shareholders: The alignment of director compensation with shareholder interests through deferred stock units is generally viewed positively.
  • Employees: No direct impact on employees is mentioned in the document.
  • Customers: No direct impact on customers is mentioned in the document.
  • Suppliers: No direct impact on suppliers is mentioned in the document.
  • Creditors: No direct impact on creditors is mentioned in the document.

Next Steps

  • The document does not specify any future actions.

Key Dates

DateDescription
01/02/2025Date of the transaction where Michele J. Hooper received 112 deferred stock units.
01/06/2025Signature date of the reporting person, Faraz A. Choudhry, Attorney-in-Fact for Michele J. Hooper.

Keywords

UnitedHealth Group, UNH, Michele J. Hooper, director compensation, deferred stock units, SEC Form 4, beneficial ownership, Section 16, equity securities, stock units

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.